热和冷HCC:解病毒瘤发生和治疗
Laura Sneller1, Keshav Mathur2, Shyam Kottilil3
1College of Medicine, Drexel University College of Medicine, 2900 W Queen Ln, Philadelphia, PA 19116, USA.
Viruses
|September 27, 2025
概括
全球肝细胞癌 (HCC) 发病率正在上升. 本综述涵盖了HCC流行病学,预防和免疫治疗策略,重点是将冷瘤转化为热瘤,以获得更好的治疗结果.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 肝病学 肝病学是一种肝病学.
背景情况:
- 肝细胞癌 (HCC) 是一个主要的全球健康问题,排名第六最常见的癌症和癌症死亡率的第三大原因.
- B型肝炎和C型肝炎病毒感染是HCC的重要风险因素,通过直接和间接的机制,包括免疫衰竭,促进其致癌性.
- 即使在病毒抑制后,HCC患者的持续性免疫系统变化也可能阻碍治疗反应.
研究的目的:
- 审查HCC的流行病学和预防策略.
- 探索"热"和"冷"HCC.的独特瘤微环境.
- 总结将冷HCC瘤转化为热瘤的机制,并讨论组合检查点抑制剂治疗.
主要方法:
- 关于HCC流行病学和预防的文献综述.
- 在HCC中分析"热"和"冷"瘤微环境模型.
- 对 cold-to-hot瘤转换机制的研究综合.
- 对HCC的综合检查点抑制剂治疗的证据审查.
主要成果:
- 全球HCC发病率和死亡率正在上升.
- 在HCC中的瘤微环境可以分为"热"或"冷",影响免疫疗法反应.
- 将"冷"的HCC瘤转化为"热"的策略可能会提高免疫治疗的疗效.
结论:
- 通过乙型肝炎疫苗接种和病毒性肝炎治疗进行预防对HCC至关重要.
- 了解和操纵瘤微环境是改善HCC免疫疗法的关键.
- 组合检查点抑制剂疗法对HCC治疗有希望,特别是在"热"瘤中.
相关概念视频
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Mechanisms of Retrovirus-induced Cancers
6.9K
Retroviruses are RNA viruses that have been shown to cause cancers in diverse species, including chickens, mice, cats, and monkeys. The RNA genomes of these viruses are first reverse-transcribed into single and then double-stranded DNA (dsDNA) copies. This dsDNA called proviral DNA then integrates into the host genome. Subsequently, the host cell transcribes the proviral DNA in concert with the chromosomal DNA. This leads to the production of viral RNA and proteins that assemble at the host...
6.9K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Tumor Immunotherapy
1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K


